These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 32639587)

  • 1. Primary large B-cell lymphoma of the central nervous system with cyclin D1 expression and t(11;14) (IGH-CCND1): Diffuse large B-cell lymphoma with CCND1 rearrangement or mantle cell lymphoma?
    Parrott AM; Haggiagi AM; Murty VV; Bhagat G; Alobeid B
    Hematol Oncol; 2020 Dec; 38(5):817-822. PubMed ID: 32639587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclin D1-positive diffuse large B-cell lymphoma with IGH-CCND1 translocation and BCL6 rearrangement: a report of two cases.
    Al-Kawaaz M; Mathew S; Liu Y; Gomez ML; Chaviano F; Knowles DM; Orazi A; Tam W
    Am J Clin Pathol; 2015 Feb; 143(2):288-99. PubMed ID: 25596256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of CD5/SOX11 double-negative pleomorphic mantle cell lymphoma.
    Chuang WY; Chang H; Shih LY; Lin TC; Yeh CJ; Ueng SH; Kuo MC; Kao HW; Liu H; Chang ST; Lee CL; Huang KP; Wang TH; Wan YL; Yu JS; Hsueh C; Chuang SS
    Virchows Arch; 2024 Aug; 485(2):323-334. PubMed ID: 38733379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SOX11 is useful in differentiating cyclin D1-positive diffuse large B-cell lymphoma from mantle cell lymphoma.
    Hsiao SC; Cortada IR; Colomo L; Ye H; Liu H; Kuo SY; Lin SH; Chang ST; Kuo TU; Campo E; Chuang SS
    Histopathology; 2012 Oct; 61(4):685-93. PubMed ID: 22642745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of CD5/Cyclin D1 Double-negative Pleomorphic Mantle Cell Lymphoma: A Clinicopathologic, Genetic, and Gene Expression Study.
    Chuang WY; Chang ST; Yuan CT; Chang GJ; Chang H; Yeh CJ; Ueng SH; Kao HW; Wang TH; Wan YL; Shih LY; Chuang SS; Hsueh C
    Am J Surg Pathol; 2020 Feb; 44(2):232-240. PubMed ID: 31688139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SOX11+ Large B-Cell Neoplasms: Cyclin D1-Negative Blastoid/Pleomorphic Mantle Cell Lymphoma or Large B-Cell Lymphoma?
    Li S; Tang G; Jain P; Lin P; Xu J; Miranda RN; Cheng J; Yin CC; You MJ; Wang ML; Medeiros LJ
    Mod Pathol; 2024 Feb; 37(2):100405. PubMed ID: 38104893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pleomorphic mantle cell lymphoma morphologically mimicking diffuse large B cell lymphoma: common cyclin D1 negativity and a simple immunohistochemical algorithm to avoid the diagnostic pitfall.
    Chuang WY; Chang H; Chang GJ; Wang TH; Chang YS; Wang TH; Yeh CJ; Ueng SH; Chien HP; Chang CY; Wan YL; Hsueh C
    Histopathology; 2017 May; 70(6):986-999. PubMed ID: 28032914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and clinical implications of cyclin D1 expression in diffuse large B-cell lymphoma (DLBCL) treated with immunochemotherapy: a report from the International DLBCL Rituximab-CHOP Consortium Program.
    Ok CY; Xu-Monette ZY; Tzankov A; O'Malley DP; Montes-Moreno S; Visco C; Møller MB; Dybkaer K; Orazi A; Zu Y; Bhagat G; Richards KL; Hsi ED; Han van Krieken J; Ponzoni M; Farnen JP; Piris MA; Winter JN; Medeiros LJ; Young KH
    Cancer; 2014 Jun; 120(12):1818-29. PubMed ID: 24648050
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Large B-cell lymphomas with CCND1 rearrangement have different immunoglobulin gene breakpoints and genomic profile than mantle cell lymphoma.
    Özoğul E; Montaner A; Pol M; Frigola G; Balagué O; Syrykh C; Bousquets-Muñoz P; Royo R; Fontaine J; Traverse-Glehen A; Bühler MM; Giudici L; Roncador M; Zenz T; Carras S; Valmary-Degano S; de Leval L; Bosch-Schips J; Climent F; Salmeron-Villalobos J; Bashiri M; Ruiz-Gaspà S; Costa D; Beà S; Salaverria I; Giné E; Quintanilla-Martinez L; Brousset P; Raffeld M; Jaffe ES; Puente XS; López C; Nadeu F; Campo E
    Blood Cancer J; 2024 Sep; 14(1):166. PubMed ID: 39313500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An Uncommon Case of Double-Hit Mantle Cell Lymphoma That Demonstrates a Transformation Process.
    Zhou J; Hu L; Zuo M; Zhou Y; Li G; Zhang X
    Am J Clin Pathol; 2020 Jan; 153(1):49-57. PubMed ID: 31433838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclin D1 expression and polysomy in lymphocyte-predominant cells of nodular lymphocyte-predominant Hodgkin lymphoma.
    Cho BB; Kelting SM; Gru AA; LeGallo RD; Pramoonjago P; Goldin TA; Heitz CT; Aguilera NS
    Ann Diagn Pathol; 2017 Feb; 26():10-15. PubMed ID: 28038705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular characterization of a rare case of high-grade B-cell lymphoma with MYC, BCL2, BCL6, and CCND1 rearrangements.
    Monika F; Sabri A; Cantu D; Vail E; Siref A
    J Hematop; 2024 Sep; 17(3):155-161. PubMed ID: 38914869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mantle cell lymphomas with concomitant MYC and CCND1 breakpoints are recurrently TdT positive and frequently show high-grade pathological and genetic features.
    Aukema SM; Croci GA; Bens S; Oehl-Huber K; Wagener R; Ott G; Rosenwald A; Kluin PM; van den Berg E; Bosga-Bouwer AG; Hoogendoorn M; Hoster E; Bittmann I; Nagel I; Murga Penas EM; Kreuz M; Bausinger J; Belder W; Oschlies I; Dyer MJS; Jayne S; Siebert R; Klapper W
    Virchows Arch; 2021 Jul; 479(1):133-145. PubMed ID: 33528622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical, morphologic, phenotypic, and genetic evidence of cyclin D1-positive diffuse large B-cell lymphomas with CYCLIN D1 gene rearrangements.
    Juskevicius D; Ruiz C; Dirnhofer S; Tzankov A
    Am J Surg Pathol; 2014 May; 38(5):719-27. PubMed ID: 24722063
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD5-negative blastoid variant mantle cell lymphoma: a diagnostic dilemma.
    Yamamoto N; Maeshima AM; Taniguchi H; Makita S; Fukuhara S; Munakata W; Suzuki T; Maruyama D; Izutsu K
    Hum Pathol; 2021 May; 111():84-91. PubMed ID: 33727166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of t(12;14)(p13;q32) in a patient with IGH-CCND1 negative mantle cell lymphoma resembling ultra-high risk chronic lymphocytic leukemia.
    Miao Y; Wang R; Fan L; Qiu H; Wu Y; Chen Y; Xu W; Li J
    Int J Clin Exp Pathol; 2015; 8(6):7494-8. PubMed ID: 26261659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma With Secondary Acquisition of t(11;14)(q13;q32)/CCND1-IGH: A Rare Variant Of Richter Transformation to Mantle Cell Lymphoma.
    Zhao Y; McCracken J; Rehder C; Wang E
    Clin Lymphoma Myeloma Leuk; 2022 May; 22(5):e310-e313. PubMed ID: 34840090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD5-negative blastoid variant mantle cell lymphoma with complex CCND1/IGH and MYC aberrations.
    Seok Y; Kim J; Choi JR; Kim YR; Park SJ; Kim SJ; Song J; Lee KA
    Ann Lab Med; 2012 Jan; 32(1):95-8. PubMed ID: 22259787
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CCND2 rearrangements are the most frequent genetic events in cyclin D1(-) mantle cell lymphoma.
    Salaverria I; Royo C; Carvajal-Cuenca A; Clot G; Navarro A; Valera A; Song JY; Woroniecka R; Rymkiewicz G; Klapper W; Hartmann EM; Sujobert P; Wlodarska I; Ferry JA; Gaulard P; Ott G; Rosenwald A; Lopez-Guillermo A; Quintanilla-Martinez L; Harris NL; Jaffe ES; Siebert R; Campo E; Beà S
    Blood; 2013 Feb; 121(8):1394-402. PubMed ID: 23255553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of D-cyclin proteins in hematolymphoid neoplasms: lack of specificity of cyclin-D2 and D3 expression in lymphoma subtypes.
    Metcalf RA; Zhao S; Anderson MW; Lu ZS; Galperin I; Marinelli RJ; Cherry AM; Lossos IS; Natkunam Y
    Mod Pathol; 2010 Mar; 23(3):420-33. PubMed ID: 20062012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.